Literature DB >> 20518313

[Effects of Panax notoginseng saponins on ACE2 and TNF-alpha in rats with post-myocardial infarction-ventricular remodeling].

Jie-Wen Guo1, Li-Ming Li, Guang-Qing Qiu, Zhi-Jun Deng, Yong-Heng Fu, Min Yang, Jing-Qiang Pan, Ruo-Xuan Liu.   

Abstract

OBJECTIVE: To research the effects of Panax notoginseng saponins (PNS) on angiotensin-converting enzymes 2 ( ACE2) and tumor necrosis factor-alpha (TNF-alpha) in rats with post-myocardial infarction ventricular remodeling.
METHODS: Models of acute myocardial infarction (AMI) were produced by ligation of left anterior descending coronary artery, 24 hours after operation the rats were randomly divided into control and experiment groups, then respectively administrated with NS, fosinopril and low, middle and high dosage of PNS for four consecutive weeks. To observe effects of PNS on malondialdehyde (MDA), nitric oxide (NO), glutathione peroxidase (GSH-Px), ACE2 and TNF-alpha in rats with post-myocardial infarction ventricular remodeling.
RESULTS: Compared with NS group, MDA significantly decreased, the activity of GSH-Px significantly increased (P < 0.05 or P < 0.01), NO of the high-dose PNS group decreased (P < 0.05), Compared with the NS group, ACE2 increased and TNF-a significantly decreased in low-dose PNS group, middle and high-dose groups (P < 0.05).
CONCLUSION: PNS can stimulate ACE2 to inhibit the expression of TNF-alpha and enhance the antioxidance. PNS can reduce pathological injury of cardiac myocytes in myocardial ischemia and cardiac muscle, which can improve ventricular remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518313

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  9 in total

1.  Exploring mechanisms of Panax notoginseng saponins in treating coronary heart disease by integrating gene interaction network and functional enrichment analysis.

Authors:  Gui Yu; Jie Wang
Journal:  Chin J Integr Med       Date:  2016-05-16       Impact factor: 1.978

Review 2.  Oral Panax notoginseng Preparation for Coronary Heart Disease: A Systematic Review of Randomized Controlled Trials.

Authors:  Qinghua Shang; Hao Xu; Zhaolan Liu; Keji Chen; Jianping Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-20       Impact factor: 2.629

Review 3.  Xuesaitong soft capsule (chinese patent medicine) for the treatment of unstable angina pectoris: a meta-analysis and systematic review.

Authors:  Xiaochen Yang; Xingjiang Xiong; Heran Wang; Guoyan Yang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-30       Impact factor: 2.629

Review 4.  Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies.

Authors:  Xiaochen Yang; Xingjiang Xiong; Heran Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-24       Impact factor: 2.629

5.  BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine.

Authors:  Zhongyang Liu; Feifei Guo; Yong Wang; Chun Li; Xinlei Zhang; Honglei Li; Lihong Diao; Jiangyong Gu; Wei Wang; Dong Li; Fuchu He
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

6.  Intervention Effects of Atorvastatin Combined with Panax notoginseng Saponins on Rats with Atherosclerosis Complicated with Hepatic Injury.

Authors:  Qing-Fang Jiang; Min-Yi Huang; Kang-Yuan Wu; Jie-Ling Weng; Rong-Gui Deng; Xin-Jie Xu; Jian-Pei Xu; Tao Jiang
Journal:  Pharmacogn Mag       Date:  2017-07-19       Impact factor: 1.085

Review 7.  Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview.

Authors:  Lian Duan; Xingjiang Xiong; Junyuan Hu; Yongmei Liu; Jun Li; Jie Wang
Journal:  Front Pharmacol       Date:  2017-10-17       Impact factor: 5.810

8.  Multitarget Effects of Danqi Pill on Global Gene Expression Changes in Myocardial Ischemia.

Authors:  Qiyan Wang; Hui Meng; Qian Zhang; Tianjiao Shi; Xuefeng Zhang; Mingyan Shao; Linghui Lu; Jing Wang; Wei Wang; Chun Li; Yong Wang
Journal:  Int J Genomics       Date:  2018-02-01       Impact factor: 2.326

9.  Human salivary histatin-1 (Hst1) promotes bone morphogenetic protein 2 (BMP2)-induced osteogenesis and angiogenesis.

Authors:  Ping Sun; Andi Shi; Chenxi Shen; Yi Liu; Gang Wu; Jianying Feng
Journal:  FEBS Open Bio       Date:  2020-06-29       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.